Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
JYNT
Strong BuyPremium GrowerFLAGThe Joint Corp. · Healthcare · United States · $119M · Avg Vol: $689K/d
Insufficient evidence for a screen-pass. The Joint Corp.: fails the quant gate on value (Q72/V33/M72; every leg must be >= 50). Absence of evidence is neutral; nothing adverse is known.
COMPANY DESCRIPTION
The Joint Corp. operates, manages, and franchises chiropractic clinics across the United States, offering an affordable and convenient walk-in model for chiropractic care. The company focuses on patient accessibility and a membership-based payment system, disrupting traditional chiropractic practices. Its expanding franchise network and consumer-centric approach position it as a growth leader in accessible chiropractic services.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 101.3M | 47.0M | 52.2M | 54.9M | -18.5% | 58.5M | 60.9M | 62.6M | 6.8% |
| EPS | 0.08 | -0.66 | -0.57 | 0.19 | 33.4% | 0.14 | 0.13 | 0.64 | 82.8% |
| Shares | 14.5M | 14.8M | 15.2M | 14.1M | -2.7% | 14.1M | — | — | — |
| Debt | 26.1M | 2.9M | 0.8M | 2.0M | -57.4% | 2.0M | — | — | — |
| Equity | 32.6M | 24.7M | 20.7M | 15.1M | -22.7% | — | — | — | — |
| Op CF | 8.2M | 14.7M | 9.4M | 1.8M | -39.3% | 5.4M | — | — | — |
| Inv CF | -17.9M | -6.2M | -0.6M | 6.3M | — | — | — | — | — |
| Fin CF | 0.3M | 0.2M | -2.0M | -9.8M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of JYNT are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| JYNT | The Joint Corp.(you) | $119M | 84 | Strong Buy |
| BTMD | biote Corp. | $53M | 88 | Strong Buy |
| CYH | Community Health Systems, Inc. | $413M | 73 | Buy |
| GMRS | GMR Solutions Inc. | $681M | 72 | Buy |
| PARK | Park Dental Partners, Inc. | $99M | 39 | Hold |
| WW | WW International, Inc. | $162M | 41 | Hold |
| STLN | The Oncology Institute, Inc. | $629M | 63 | Hold |
| ARDT | Ardent Health, Inc. | $1.5B | 88 | Strong Buy |
| ASTH | Astrana Health, Inc. | $1.9B | 83 | Strong Buy |
| AIRS | AirSculpt Technologies, Inc. | $187M | 33 | Sell |
Peer medians: ROE -30.2% · P/E 26.9x · Gross margin 57.9%